Resources/
Phil Blog
Phil Blog
Why Transparency is Critical in the Patient Access Journey
The Healthcare system is notoriously complicated and opaque, making it arduous for patients to navigate successfully. That’s why there’s been a legislative push to increase transparency across through policies such as the No Surprises Act and Hospital Pricing Transparency rule. Getting access to prescribed therapies to treat complex medical conditions can be especially difficult and stressful for patients
How Life Science Brands Can Successfully Navigate Retail Challenges
In 2021, 3 out of 4 patients who tried to fill a launch brand were unsuccessful due to payer controls. As life science companies continue to launch innovative specialty-lite therapies, adopting a distribution strategy that ensures patients can access the brand as prescribed – efficiently and affordably – can mean the difference between a successful launch and failing to reach their expected value. As the primary channel for most brands, pharmacy networks play a pivotal role in the distribution, fulfillment, and reimbursement of medications, which means the brand's short- and long-term commercial success ultimately hinges on pharmacy performance
Is Telemedicine Part of Your Brand’s Go-to-Market Strategy? Delivering an End-to-End Digital Experience is Essential
The explosion of virtual healthcare during the COVID-19 pandemic fueled the rise of digital direct-to-consumer (DTC) channels in the life sciences industry. The realization that it’s possible for patients to have a compliant, clinical conversation to receive a prescription via a telemedicine platform linked to a brand’s website can be a game-changer. A well-executed DTC model provides a more responsive option for patients to meet them where they are in 2023 - online and on their phone
Phil and RedHill Biopharma Partner to Increase Access to Talicia®
Talicia® is indicated for the treatment of Helicobacter pylori infection in adults Patients can now access RedHill’s Talicia® via the PhilRx Platform SAN FRANCISCO, Calif. – July 6, 2023 – Phil Inc., a patient access platform company that revolutionizes life science product commercialization, today announced an agreement with RedHill Biopharma (Nasdaq: RDHL) (‘RedHill’) to make its medication Talicia® (omeprazole magnesium, amoxicillin, and rifabutin) available via the PhilRx Patient Access Platform. The PhilRx Patient Access Platform provides end-to-end visibility into the entire prescription life cycle, starting the moment the physician writes a prescription
3 Reasons Why Your Patient Services Program May be Falling Short on Medication Adherence
Medication nonadherence is a long-standing problem linked to poor health outcomes, increased hospitalizations, and significantly higher healthcare costs. According to the CDC, out of the 3.8 billion prescriptions written in the U.S., one out of five are never filled. Even with good insurance and drug coverage, medication adherence rates for chronic conditions fall between 50-60%– a far cry from the 80% adherence rates medical experts say are necessary for optimal therapeutic efficacy
Ready to learn more?
Our consultants will work with you to analyze your current channel strategy and make recommendations for how to improve patient access and increase the percentage of scripts getting covered by insurance.
